Comparison of the efficacy of antidiabetic agents in type 2 diabetes with MASLD: a network meta-analysis. [PDF]
Shao X, You J, Zhang H, Jiang X.
europepmc +1 more source
Ten-Year Outcomes of Patients with Left Main Coronary Artery Disease and Diabetes Mellitus Treated with Percutaneous Coronary Intervention. [PDF]
Bresha J +14 more
europepmc +1 more source
Identifying high-risk combinations of metformin during COVID-19. [PDF]
Dimnjaković J +5 more
europepmc +1 more source
Intermittent energy restriction and risk of physician-diagnosed diabetes progression: a propensity-weighted real-world cohort study. [PDF]
Xiao Z +14 more
europepmc +1 more source
Integrative Metabolomics and Systems Pharmacology Reveal PPARγ-Centered Antidiabetic Mechanisms of <i>Caulerpa racemosa</i> and Its Bioactive Compounds. [PDF]
Nurkolis F +11 more
europepmc +1 more source
Smart Antidiabetic Nanomedicine: A Revolutionized Therapeutic Approach for Treatment of Diabetes Mellitus. [PDF]
Mohammad Karim A.
europepmc +1 more source
Long-term effectiveness on glycemic control of insulin compared to combined oral antidiabetic drugs for initial intensive treatment in newly diagnosed type 2 diabetes: A duplicated target trial. [PDF]
Kim TH +13 more
europepmc +1 more source
Outcomes in youth-onset type 2 diabetes during the transition period: glycemic control, microvascular complications, and effects of second-line agents. [PDF]
Yoo J, Lee YJ, Shin CH, Lee YA.
europepmc +1 more source
Analysis of proteins and peptides to investigate the molecular signatures of a conventional antidiabetic herb, Boerhavia procumbens Banks ex Roxb. (Nyctaginaceae). [PDF]
Hassan G +4 more
europepmc +1 more source
Self-Management, Adherence, and the Role of Pharmaceutical Care in Patients with T2DM in Primary Practice: A Cross-Sectional Survey in Bulgaria. [PDF]
Milushewa P, Chenesheva N, Petkova V.
europepmc +1 more source

